|
|
|
Praveen Advani
Director/Team Leader, Global Market Research & Analytics
Merck
Praveen Advani has more than 14 years of experience leading global market research efforts for new products and in-line brands in the
Pharmaceutical Industry. Praveen currently is the Director & Team Leader for Womens Health, Insomnia and Pain Franchises in Global Market
Research & Analytics at Merck. He has also successfully led global market research efforts for the launches of Diabetes (Januvia and
Janumet) and Glaucoma (Saflutan) drugs at Merck in the last 7 years.
Prior to Merck, Praveen was with Aventis Pharmaceuticals (now Sanofi-Aventis) for 6 years and was instrumental in leading global market
research for the successful launch of Lantus. Praveen holds a Bachelors degree in Engineering from the University of Pune, India and a M.B.A.
from Thunderbird, The American Graduate School of International Management.
_________________________________________________________________________________________________
|
|
|
|
Sandipa Dublish
Sr. Director Global MR
Alexion Pharmaceuticals
Sandipa Dublish is Sr. Director Global MR at Alexion Pharmaceuticals. In this role she manages all aspects of strategic business insights
Sandipa holds a PhD. in Marketing from Florida International University and an MBA from Faculty of Management Studies, Delhi, India.
_______________________________________________________________________________________________________________
|
|
|
|
Mark Edelstein
Former Senior Director Market Research
Lundbeck
Mark Edelstein has been an active champion for the Marketing Research function for nearly 25 years, committed to, and passionate about
raising the standards, excellence and impact of this remarkable function. Most recently, Mark joined Lundbeck Inc., in the Chicago metro area,
as Senior Director of Marketing Research for the new U.S. arm of this Copenhagen-based pharmaceutical company. Prior to joining
Lundbeck, Mark spent nearly 9 years as a global pharmaceutical marketing research consultant. From 2008-2009, he was Vice President,
Marketing Research for the new U.S. subsidiary of the Planning Shop international – a UK based pharmaceutical marketing research
consultancy. In 2001, Mark founded his own company, Mark Edelstein Consulting, Inc., where he served as President and lead consultant to
the global healthcare industry, focusing on cultivating Marketing Research and Business Intelligence. Prior to starting up his own consulting
firm, he spent 15 years on the healthcare manufacturer ("client") side, working for such Pharmaceutical leaders as Pharmacia, Abbott
Laboratories, Searle (Monsanto), and Merck & Co. Over that time, Mark was the lead market researcher driving the development and launches
of some of the industry’s most successful products, including Prilosec™, Biaxin™, Depakote™, and Celebrex™. Under his leadership,
Marketing Research has brought marketing insight and perspective to guide many other products in pre-clinical, launch and mature life-cycle
stages.
Currently, Mr. Edelstein is serving as a mentor-coach for students enrolled in a new online certification program for marketing researchers
worldwide: Principles of Pharmaceutical Marketing Research – sponsored by the University of Georgia. He is very excited to be a part of this
revolutionary new course, and excited to work together with new colleagues from around the globe
Mark began his professional career as a practicing Chemical Engineer for nearly 10 years, crediting his experiences at FMC and Procter &
Gamble with teaching him the art and skill of problem solving, project management, and the critical importance of collaborative work
relationships. He holds a Bachelor’s Degree in Chemical Engineering from Lehigh University in Bethlehem, Pennsylvania, and a Master’s
Degree in Marketing from Drexel University, Philadelphia, Pennsylvania.
_______________________________________________________________________________________________________________
|
|
|
|
Stuart Greenberg
Deputy Director, Global/Oncology Market Research
Bayer
Dr. Stuart E. Greenberg is currently Deputy Director, Global / Oncology Market Research at Bayer. His responsibilities include qualitative and
quantitative primary research, secondary research, forecasting and market size and structure analysis. In the past he has been on the Global
Market Research teams of Pfizer, Pharmacia, Searle, Roche Diagnostics and Boehringer Mannheim. Stuart has managed market research on
cancer treatment and prevention drugs, blood glucose monitors, point of care testing equipment and ophthalmic instruments. Stuart earned
his undergraduate degree from Lafayette College and achieved a Masters and PhD in Industrial/Organizational Psychology at Virginia Tech.
He currently resides in Central New Jersey with his wife Randi and children, Max and Dena.
_______________________________________________________________________________________________________________
|
| |
|
Anne Hale
Senior Director/Team Leader
Pfizer
_______________________________________________________________________________________________________________
|
|
|
|
Elys Roberts
President
Ipsos Health
Elys manages the North American team of Ipsos Health, one of the largest market research agencies in the industry. Spanning over 15 years,
his diverse background in the healthcare sector includes market research, sales and marketing and management positions on the client-side,
agency-side and fieldwork supplier.
Prior to Ipsos, he founded and served as Group President for Medefield America rapidly shaping it into one of the largest and most successful
providers of global online physician fieldwork in the industry.
Previously, he was head of Global Market Research Business Training at NOP Health (now GfK) and headed one the company’s marketing
research Strategic Business Units. Working client side, Elys spent seven years in Eli Lilly’s Sales and Marketing leadership program in Europe
in diverse roles including Market Research Manager, Marketing and District Sales Manager.
Elys is on the Board of MRII (a non-profit) and is co-editor for their learning program the Principles of Pharmaceutical Marketing Research. He
graduated with a B.A.(summa cum laude) from Manchester University, England and holds an exam Distinction from the Association of the
British Pharmaceutical Industry.
__________________________________________________________________________________________________________________________________
|
| |
|
David Rosen
Director of Market Research
Purdue Pharmaceuticals
_______________________________________________________________________________________________________________
|
| |
|
Grace Samoil-Reynolds
Sr Director Global Strategic Analytics
Johnson & Johnson
Grace joined Johnson & Johnson in 1997 in the Market Research Department at Personal Products (consumer). She then progressed through
roles in Market Research and Forecasting management in the Pharmaceutical Sector, including responsibility for Women’s Health, Urology
and Pain at Ortho McNeil. Most recently, she is responsible for Market Research and Forecasting for the CNS and Pain Franchises in early
Pharmaceutical Development. She also has experience in Oncology, Anemia, Metabolics, and Mens Health. Prior to J&J, Grace worked at
Schering Plough and Colgate Palmolive, primarily in a Market Research capacity.
Grace earned her MBA at Rutgers University in New Jersey and holds a Bachelors in Chemistry from McGill University, Montreal, Canada. Her
passion is driving innovation and future thinking.
_______________________________________________________________________________________________________________
|
| |
|
Jaya Subramaniam
Executive Director, MR Oncology
Bristol-Myers Squibb
__________________________________________________________________________________________________________________________________
|
|
|
|
Jocelyn Trokenheim
Sr. Director, Business Development
Takeda Pharmaceuticals
Jocelyn Trokenheim is Sr. Director, Business Development, at Takeda Pharmaceuticals North America, Inc. In this role, Ms. Trokenheim is
responsible for assessments and valuations of licensing, and merger and acquisition opportunities. Her efforts had contributed to Takeda’s
recent acquisition of Nycomed, the largest acquisition ever completed by Takeda and the second largest acquisition ever completed by a
Japanese company.
Prior to assuming the Business Development role, Ms. Trokenheim was Sr. Director, Business Insights and Strategy, at Takeda
Pharmaceuticals North America, Inc. Ms. Trokenheim built and led a department of 28 professionals, with responsibilities spanning across all
aspects of commercial analytics including forecasting, marketing analytics, decision science, market research, commercial reporting and data
governance, for all of Takeda’s in-market products, pipeline compounds, as well as business development opportunities. In addition to her
expertise in analytics, Ms. Trokenheim is an accomplished leader in developing in-house analytical capabilities and building skilled teams to
increase cross-functional collaborations and organizational efficiency.
Ms. Trokenheim started her career with ZS Associates, as one of the founding members of its market research practice while gaining
extensive experience in pharmaceutical sales and marketing analytics. Ms. Trokenheim has a B.S. and an MSBA degree in Business Analysis
from San Francisco State University, and received an MSc degree in Management Science from Queen’s University in Kingston, Ontario,
Canada.
__________________________________________________________________________________________________________________________________
|
| |
|
Tjun Wong
Senior Director, Global Marketing Research
Shire Pharmaceuticals
__________________________________________________________________________________________________________________________________
|
|
